How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

For more than four decades, POWER magazine has honored top performers in the electricity-generating industry with annual awards. If your plant has distinguished itself through innovative design, ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

The Major League Baseball trade deadline is exactly one week away, set for Aug. 3. Thanks in part to the playoffs having expanded (again) before the 2022 season and a general state of mediocrity, ...

Forgot to unplug the iron this morning? The top smart plugs, outlets, and power strips we've tested let you control anything you can plug into the wall from your phone. I'm PCMag's managing editor for ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Total new-vehicle sales for July 2026, including retail and non-retail transactions, are projected to reach 1,415,800, a 1.4% increase year-over-year, according to a joint forecast from JD Power and ...